Enzon Pharmaceuticals, Inc. (ENZND)
4.03
-1.85
(-31.46%)
USD |
OTCM |
Mar 25, 16:00
Enzon Pharmaceuticals EPS Diluted (Quarterly) : -2.159 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | -1.203 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.071M |
| Total Expenses (Quarterly) | 1.071M |
| Enterprise Value | 5.024M |
| Earnings Yield | -150.1% |
| Normalized Earnings Yield | -69.38 |